Drug Shortage Report for APIDRA
Report ID | 170358 |
Drug Identification Number | 02279479 |
Brand name | APIDRA |
Common or Proper name | APIDRA CARTRIDGE |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | INSULIN GLULISINE |
Strength(s) | 100UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 5 cartridges |
ATC code | A10AB |
ATC description | INSULINS AND ANALOGUES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-09-23 |
Estimated end date | 2022-10-24 |
Actual end date | 2022-10-11 |
Shortage status | Resolved |
Updated date | 2022-10-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-09-27 | English | Compare |
v2 | 2022-09-27 | French | Compare |
v3 | 2022-10-12 | English | Compare |
v4 | 2022-10-12 | French | Compare |
Showing 1 to 4 of 4